Jonathan Wagg - Concepedia

Author

Jonathan Wagg

Roche (Switzerland)

Also Known As

J Wagg, J. Wagg, Jonathan K Wagg, Jonathan Wagg, Wagg, Jonathan

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Roche (Switzerland)University of Oxford Roche (United Kingdom)SRI International

About

Jonathan Wagg is an author at Roche (Switzerland) specializing in medicine, drug discovery, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	614
2	Biology	1	1	441
3	Immunology	1	1	15
4	Microbiology	1	1	441
5	Molecular Biology	1	1	158

Jonathan Wagg

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Computational prediction of human metabolic pathways from the complete human genome Pedro Romero, Jonathan Wagg, Michelle Green, Genome biology	2004	533
The complete genome sequence of Francisella tularensis, the causative agent of tularemia Pär Larsson, Petra C. F. Oyston, Patrick Chain, Nature Genetics BiologyComplete Genome SequenceComparative GenomicsGeneticsPathogenesis	2005	441
Integrated pathway–genome databases and their role in drug discovery Peter D. Karp, Markus Krummenacker, Suzanne Paley, Trends in biotechnology Functional GenomicsBioinformatics DatabaseBiological DatabaseMolecular BiologyPathway Analysis	1999	158
Models and Machines: How Deep Learning Will Take Clinical Pharmacology to the Next Level Lucy Hutchinson, Bernhard Steiert, Antoine Soubret, CPT Pharmacometrics & Systems Pharmacology	2018	51
Two distinct clinical patterns of checkpoint inhibitor-induced thyroid dysfunction Anna Olsson‐Brown, Rosemary Lord, Joseph J. Sacco, Endocrine Connections	2020	29
Quantifying the limits of CAR T-cell delivery in mice and men Liam Brown, Eamonn A. Gaffney, Ann Ager, Journal of The Royal Society Interface	2021	29
Combining Mathematical Models With Experimentation to Drive Novel Mechanistic Insights Into Macrophage Function Joanneke E. Jansen, Eamonn A. Gaffney, Jonathan Wagg, Frontiers in Immunology	2019	18
Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue Mark Stroh, Chi‐Chung Li, Jonathan Wagg, CPT Pharmacometrics & Systems Pharmacology Tumor ImmunologyQuantitative Clinical PharmacologyCancer ImmunosurveillanceMedicineImmunology	2015	15
Modeling Longitudinal Preclinical Tumor Size Data to Identify Transient Dynamics in Tumor Response to Antiangiogenic Drugs H. Peter Mueller, Eamonn A. Gaffney, P. K. Maini, CPT Pharmacometrics & Systems Pharmacology	2016	15

Page 1